Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Peter Attia MDPeter Attia MD

188 - [AMA #30 Sneak Peek] How to Read and Understand Scientific Studies

Watch the full episode here: https://bit.ly/3e4ibB4 In this “Ask Me Anything” (AMA) episode, Peter and Bob dive deep into all things related to studying studies to help one sift through all the noise to find the signal. They define the various types of studies, how a study progresses from idea to execution, and how to identify study strengths and limitations. They explain how clinical trials work, as well as the potential for bias and common pitfalls to watch out for. They dig into key factors that contribute to the rigor (or lack thereof) of an experiment, and they discuss how to measure effect size, differentiate relative risk from absolute risk, and what it really means when a study is statistically significant. Finally, Peter lays out his personal process when reading through scientific papers. In this sneak peek, we discuss: 00:00 - Intro 00:10 - The ever changing landscape of scientific literature 02:44 - The process for a study to progress from idea to design to execution 06:39 - The various types of studies and how they differ 20:22 - The different phases of a clinical trial In the full episode, we also discuss: -Observational studies and the potential for bias; -Experimental studies: Randomization, blinding, and other factors that make or break a study; -Power, p-values, and statistical significance; -Measuring effect size: Relative risk vs. absolute risk, hazard ratios, and “Number Needed to Treat”; -How to interpret confidence intervals; -Why a study might be stopped before its completion; -Why only a fraction of studies are ever published and how to combat publication bias; -Why certain journals are more respected than others; -Peter’s process when reading a scientific paper; and More. -------- About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 35 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://bit.ly/3p8M9du Subscribe to receive exclusive subscriber-only content: https://bit.ly/3EaHqMN Sign up to receive Peter's email newsletter: https://bit.ly/3GXLi5q Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle

Peter AttiahostBobhost
Dec 20, 202131mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

At a glance

WHAT IT’S REALLY ABOUT

Peter Attia Explains How Scientific Studies Are Designed, Categorized, and Phased

  1. Attia describes the path of an experimental study from a null and alternative hypothesis through experimental design, power analysis, IRB approval, defined outcomes, a statistics plan, pre-registration, and funding.
  2. Studies fall into observational, experimental, and summary or review categories, ranging from case reports and cohort studies to randomized controlled trials and meta-analyses.
  3. Attia and Bob stress that randomization removes the selection bias that undermines non-randomized trials, and that a meta-analysis is only as good as the studies it pools.
  4. Attia lays out the four phases of FDA-style human drug trials, from small dose-escalation safety studies to large randomized phase three trials and post-marketing phase four studies.
  5. The conversation was motivated by listener questions and Attia's wish to give people a digestible way to separate signal from noise in the research news cycle.

IDEAS WORTH REMEMBERING

5 ideas

Good science starts with a clearly framed hypothesis.

Attia says the cleanest approach is to state a null hypothesis of no relationship and an alternative hypothesis, using the coffee-and-eye-color example, and notes even this involves nuance about what outcome is being specified.

Much happens before a study begins.

Design choices, power analysis for sample size, IRB ethics approval, primary and secondary outcomes, a statistical plan, pre-registration, and funding all come before running the experiment.

Observational studies can generate hypotheses but struggle to show causality.

Case reports and case series are not generalizable, and cohort studies, whether retrospective or prospective, can reveal patterns without establishing that one thing caused another.

Randomization is what protects against bias.

In non-randomized trials there is a reason people end up in a given group, such as choosing a statin versus ezetimibe, and that reason introduces bias that randomization is meant to remove.

A meta-analysis is not automatically better than a randomized trial.

Attia disagrees with pyramids that rank meta-analyses above randomized trials, quoting the line that a thousand sows' ears don't make a pearl necklace, and says each constituent study must still be examined.

WORDS WORTH SAVING

5 quotes

So if you do a meta-analysis of a bunch of garbage studies, you get a garbage meta-analysis. So it, it can't, uh, it can't clean garbage. Um, it, it simply can aggregate it.

— Peter Attia

You don't get a pass at examining each of the constitutive studies within a meta-analysis

— Peter Attia

Um, I mean, in theory, it should start with a hypothesis. Uh, good science is generally hypothesis-driven.

— Peter Attia

So you make an observation, you say, "Hmm, that's strange."

— Bob

Every treatment has side effects. It's just that it doesn't have, um, side effects that are deemed unacceptable for the risk profile of the patient

— Peter Attia

Hypothesis-driven science and the null hypothesisSteps in experimental study designObservational study typesRandomized vs. non-randomized trialsStrengths and limits of meta-analysesPhases one through four of clinical trialsSeparating signal from noise in research news

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.